// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Hypothalamic miR-30 regulates puberty onset via repression of the puberty-suppressing factor, Mkrn3

Juan M Castellano - European Congress of Endocrinology (ECE) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Glycemic variability and mortality in patients hospitalized to general surgery wards

Alexander Gorshtein - European Congress of Endocrinology (ECE) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Biochemical and clinical features of a family with a novel mutation of CYP24A1

Alessandro Brancatella - European Congress of Endocrinology (ECE) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Ergocalciferol

Modes and actions of inter-individual transfer of estradiol and progesterone among conspecifics in both mice and bats

Denys deCatanzaro - European Congress of Endocrinology (ECE) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Alora

Navigating thyroid storm: The role of plasmapheresis in a patient also needing urgent aortic valve replacement surgery

Richa Parihar - European Congress of Endocrinology (ECE) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Severe Aortic Stenosis

Propylthiouracil

Transgenic production of endogenous n-3 PUFA levels compared to fish oil intake differentially improve obesity-related metabolic disorders: role of the gut microbiota

Melanie Le Barz - European Congress of Endocrinology (ECE) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Nonalcoholic fatty liver disease

N/A

Phase 3 Results for Dasiglucagon as a Fast and Effective Treatment for Severe Hypoglycemia

THOMAS R. PIEBER - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Effect of Dapagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, on Vascular Function in Patients with Type 2 Diabetes Compared with Gliclazide

SOO LIM - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 2 diabetes mellitus

Dapagliflozin

A Genetic Locus on Chromosome 1p36 Associated with Cardiovascular Autonomic Neuropathy in Type 2 Diabetes

YALING TANG - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Diabetic neuropathy

N/A

A Longitudinal Multinational Consortium Study

BRUCE A. PERKINS - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Peripheral neuropathy

N/A

Effect of Alirocumab in Individuals with Type 2 Diabetes and High Triglycerides and Low High-Density Lipoprotein Cholesterol

HELEN M. COLHOUN - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 2 diabetes mellitus

Fenofibrate

Dorsal Vagal Complex Is a Site for Brain Lipid Sensing to Regulate Lipid Homeostasis

BATTSETSEG BATCHULUUN - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Dyslipidemia

cyclodextrin

FIT Untethered Study

RONNIE ARONSON - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hyperglycemia

Insulin degludec

Patient Perceptions vs. Expert Analyses via a Novel Phone App

MELANIE B. GILLINGHAM - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 1 diabetes mellitus

N/A

A Subanalysis of the BALANCE 205 Study

RICHARD E. PRATLEY - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Prediabetes

Efpeglenatide

A Randomized Controlled Trial vs. Gliclazide

ERIK J.M. VAN BOMMEL - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Dapagliflozin

Empagliflozin and Cardiorenal Outcomes in Patients with Nonproteinuric Kidney Disease in the EMPA-REG OUTCOME Trial

SILVIO E. INZUCCHI - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Chronic kidney disease

BI-10773

A Predefined Analysis from the DECLARE-TIMI 58 Randomised, Placebo-Controlled Trial

ITAMAR RAZ - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Albuminuria

N/A

The Cost of Chronic Kidney Disease Progression in Type 2 Diabetes Patients

LAWRENCE BLONDE - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Chronic kidney disease

N/A

Placental Growth Factor and Fetal Growth in Women with Type 1 Diabetes Mellitus

SIOBHAN BACON - American Diabetes Association (ADA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 1 diabetes mellitus

N/A

Copyright © 2026. QuantiNova All rights reserved